Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Jens O. Watzlawik
Mayo Clinic
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
43
TOTAL CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
N-of-1 CHCHD10 ALS Antisense Oligonucleotide Trial Shows Early Signs of Efficacy
Number of pages: 6
Posted: 25 Jul 2025
Margot A. Cousin
,
Aditi I. Dagli
,
Laurence Mignon
,
Jaimin S. Shah
,
Mercedes Prudencio
,
Tania F. Gendron
,
Marka Van Blitterswijk
,
Erik H. Middlebrooks
,
Megan Donahue
,
Jany Dagher
, Jens O. Watzlawik,
Wolfdieter Springer
,
Zachary McEachin
,
Leonard Petrucelli
and
Bjorn Oskarsson
Mayo Clinic, Orlando Health, n-Lorem Foundation, Mayo Clinic, Mayo Clinic, Mayo Clinic, Mayo Clinic, Mayo Clinic, Mayo Clinic, Mayo Clinic, Mayo Clinic, Mayo Clinic, Emory University, Mayo Clinic - Florida and Mayo Clinic
Downloads
43
(1,145,108)
View PDF
Download
Abstract:
Amyotrophic lateral sclerosis, Antisense oligonucleotide, CHCHD10, Neurofilament light
Feedback
